ResMed Joins HIMSS, Healthcare Leaders to Recognize National Health IT Week

SAN DIEGO – October 2, 2017 – ResMed joins other healthcare leaders in recognizing National Health IT Week for driving awareness and adoption of health information technology to help improve healthcare.

Started in 2006 by the Healthcare Information and Management Systems Society (HIMSS), NHIT Week is an annual reminder of the significant benefits health IT brings to improving patients’ health while also reducing the cost of healthcare.

“Every new ResMed sleep apnea and life support ventilation device can be cloud connected for remote patient monitoring and self-monitoring,” said Raj Sodhi, president of Software-as-a-Service (SaaS) and Healthcare Informatics at ResMed. “This helps provide patients with a more engaging and inclusive therapy experience, maximize their therapy adherence and save clinicians valuable time.”

Remote patient monitoring on the rise

More than seven million patients worldwide are remotely monitored by one or more medical devices, a 45 percent increase from 2015, according to tech analyst Berg Insight. ResMed leads the world with more than three million patients remotely monitored on CPAP (continuous positive airway pressure) devices and respiratory care ventilators, according to Berg Insight.

NHIT Week consists of events across the country, including National Health IT Week participants – vendors, provider organizations, payers, pharmaceutical/biotech companies, government agencies, industry/professional associations, research foundations, and consumer protection groups – all working together to elevate national attention to the advantages of advancing health IT.

All week, @ResMed will be tweeting health IT stats with the hashtag #NHITweek.

# # #

MEDIA: Jayme Rubenstein, 858.836.6798, | INVESTORS: Agnes Lee, 858.836.5971,
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798


Receive ResMed news releases when they publish.


ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages